Physician profile
Peter Redko
NPI 1750456687
$861.74
in general payments reported to CMS, 2019-2025
11 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.34 · 2020: $47.46 · 2021: $157 · 2022: $36.36 · 2023: $163 · 2024: $235 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $328.67 | 2024-2025 | |
| Smith+Nephew, INC. | $193.76 | 2021-2023 | Renasys Go V2 Home, Pico |
| Integra Lifesciences Corporation | $80.56 | 2019-2020 | |
| Orthofix Medical, INC. | $52.97 | 2023 | Physio-Stim |
| Biowound Solutions, INC. | $37.76 | 2025 | Bio-Connekt |
| Stryker Corporation | $36.88 | 2023 | Viaflow |
| Derma Sciences, INC. | $33.18 | 2019 | |
| Abbott Laboratories | $32.56 | 2023 | Proclaim |
| Osiris Therapeutics INC. | $25.06 | 2019 | |
| Paragon 28, INC. | $20.34 | 2023 | Portfolio |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Redko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.